Z Squared ZSQR
NASDAQ ZSQR
$3.60 +0.00 (+0.00%)
As of: Oct 22, 2026 · 9:33 AM EDT

Z Squared (ZSQR) EBT Margin (2025 - 2026)

Updated

Z Squared's EBT Margin was -871.16% in Q2 2026, up 2663.04 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) EBT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's EBT Margin was -798.69% through Jun 30, 2026, up 12341.27 percentage points year-over-year; for FY2025, it came in at -900.72%.

  • EBT Margin shows a four-year change of +17031.66 percentage points (FY2021 to FY2025).
  • In earlier years, EBT Margin was -17932.37% in FY2021.
  • Quarterly EBT Margin has moved between -5440.95% (Q1 2025) and -188.26% (Q4 2025) over five years.
  • Per Business Quant data, ZSQR's EBT Margin in the three quarters before Q2 2026 was -3534.20% (Q1 2026), -188.26% (Q4 2025) and -1220.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn 26.66%
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn 25.18%
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn -4.11%
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn 29.63%
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn 18.19%
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 27.53%
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn -131.41%
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn -4.34%
10 Z Squared 179.13 Mn 152.37 Mn -1.77 Mn -871.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -871.16%
Mar 31, 2026 -3,534.20%
Dec 31, 2025 -188.26%
Sep 30, 2025 -1,220.84%
Mar 31, 2025 -5,440.95%
API Access

Z Squared EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY